Literature Review
-
Literature Review
Relapsing, progressive MS classifications should be abandoned
“The disease appears to be more of a continuum of disability progression, which is sometimes also accompanied by relapses.”
-
Literature Review
Circadian rhythm changes linked to future Parkinson’s disease risk
Circadian rhythmicity could be a promising intervention target and may open new opportunities for the prevention and management of Parkinson’s...
-
Literature Review
Still no clear answer on intranasal insulin for MCI and Alzheimer’s disease
Although one insulin administration device produced marked cognitive benefit, reliability was inconsistent.
-
Literature Review
Cardiovascular risk factors tied to midlife cognitive decline
Hypertension, diabetes, and smoking can affect cognition at an age much younger than previously believed.
-
Literature Review
Ticagrelor/aspirin combo: Fewer repeat strokes and deaths, but more bleeds
The combination also increased the risk for major hemorrhage, but that increase was small and would not overwhelm the benefit.
-
Literature Review
In epilepsy, brain-responsive stimulation passes long-term tests
An extension study and a real-world study both show accumulating benefits over 9 years.
-
Literature Review
Consensus document reviews determination of brain death
The recommendations are the minimum criteria for the determination of brain death or death by neurologic criteria.
-
Literature Review
Concussion linked to risk for dementia, Parkinson’s disease, and ADHD
A history of multiple concussions strengthened the association between concussion and subsequent mood and anxiety disorder, dementia, and...
-
Literature Review
Impaired senses, especially smell, linked to dementia
Even mild levels of multisensory impairment are associated with accelerated cognitive aging.
-
Literature Review
Concussion linked to risk for dementia, Parkinson’s disease, and ADHD
A history of multiple concussions strengthened the association between concussion and subsequent mood and anxiety disorder, dementia, and...
Conference Coverage
-
Conference Coverage
Population study supports migraine–dementia link
Migraine with aura confers a significantly higher risk of dementia, according to preliminary findings from a population-based cohort study in...
-
Conference Coverage
Intranasal DHE shows promise in migraine
New formulation of DHE joins other efforts to improve delivery of existing drugs.
-
Conference Coverage
Adding CGRP to Botox is safe and effective for migraine prevention
-
Conference Coverage
Influenza vaccine efficacy called undiminished in MS
Meta-analysis results are consistent with latest AAN immunization guideline.
-
News
MIS-C is a serious immune-mediated response to COVID-19 infection
Multisystem inflammatory syndrome in children (MIS-C) is still a moving target because there is much still to learn about it.
-
Conference Coverage
Flu and pneumonia vaccination tied to lower dementia risk
These preliminary data suggest that vaccination against both respiratory illnesses may lower the risk for cognitive decline and dementia.
-
Conference Coverage
A better tau blood test for diagnosing Alzheimer’s disease?
These new blood tests may enable clinicians to simply and inexpensively assess whether someone is at high risk for Alzheimer’s disease.
-
Conference Coverage
Microbiome research ‘opening doors’ to new Alzheimer’s disease treatments
"The first of a possible future generation of compounds for prevention or treatment of Alzheimer's disease may indeed be emerging," said Dr....
-
Conference Coverage
P-tau217 differentiates Alzheimer’s disease from other neurodegenerative conditions
Increasing blood P-tau217 levels can be detected in some individuals up to 20 years before the onset of cognitive decline.
-
Conference Coverage
‘Long sleep’ or apnea in middle age double risk for Alzheimer’s disease
“Addressing sleep problems in middle-age may play a role in improving brain health.”
-
Conference Coverage
Global study to track COVID-19’s impact on the brain
The research will track and evaluate the short- and long-term impact of the coronavirus on the brain, including cognition, behavior, and function...
-
Conference Coverage
Plasma exchange is ‘encouraging’ as a novel Alzheimer’s disease treatment
The treatment was associated with a 60% decrease in functional and cognitive decline in patients with moderate Alzheimer’s disease.
-
Conference Coverage
Twelve risk factors linked to 40% of world’s dementia cases
An update of the Lancet Commission on Dementia Prevention, Intervention, and Care adds three new modifiable risk factors.
Latest News
-
Latest News
Headache may predict clinical evolution of COVID-19
Headache onset could occur during the presymptomatic or symptomatic phase of COVID-19 and could resemble tension-type or migraine headache.
-
From the Journals
Diagnostic criteria may miss some MIS-C cases, experts say
“There is concern that children meeting current diagnostic criteria for MIS-C are the ‘tip of the iceberg,’ and a bigger problem may be lurking...
-
From the Journals
Repetitive hits to the head tied to depression, poor cognition in later life
“What’s unique about our study is that we focused on a history of [repetitive hits to the head],” said Dr. Michael Alosco.
-
Latest News
NFL’s only physician player opts out of 2020 season over COVID
“I cannot allow myself to potentially transmit the virus in our communities simply to play the sport that I love. If I am to take risks, I will do...
-
Latest News
Physician recruitment drops by 30% because of pandemic
“Physicians now may have to compete to secure practice opportunities that meet their needs,” said authors in a Merritt Hawkins report.
-
From the Journals
Sleep problems in young children linked to lower QOL in later years
While children with consistent sleep problems experienced the worse outcomes, mild sleep problems also were associated with impairment.
-
From the Journals
Stress-induced brain activity linked to chest pain in CAD patients
The brain's reaction to stress may be an important contributor to chest pain in patients with coronary artery disease, according to results of a...
-
Latest News
Pandemic effect: Telemedicine is now a ‘must-have’ service
Survey examines patients’ perception of safety and their telemedicine experience.
-
From the Journals
Since COVID-19 onset, admissions for MI are down, mortality rates are up
FDA/CDC
-
FDA/CDC
FDA approves low-sodium treatment option for narcolepsy
Xywav is a novel oxybate product with 92% less sodium than Xyrem.
-
FDA/CDC
FDA approves cannabidiol for tuberous sclerosis complex
The agency approved the drug for patients 1 year of age and older.
-
FDA/CDC
FDA approves first oral treatment for spinal muscular atrophy
The oral treatment provided a “meaningful difference from the natural progression of the disease.”
-
FDA/CDC
FDA approves viltolarsen (Viltepso) for Duchenne muscular dystrophy
The approval marks the second drug therapy for Duchenne muscular dystrophy.